take comfort in ease of use

FUROSCIX was designed to make at-home administration possible for all appropriate patients with minimal preparation and steps. In a human factor validation study, FUROSCIX and the Instructions for Use were understood and effectively used by the intended populations.1*

of critical observational use tasks were completed correctly1

of participants reported no difficulty understanding or following Instructions for Use1

60 participants (30 patients with heart failure, 15 caregivers, and 15 healthcare professionals) were recruited and completed the study. Of the 30 patients, 15 were trained and 15 were untrained. All other participants were untrained.1

*

Trained participants attended a walk-through of the Instructions for Use conducted by healthcare professionals. Participants performed all tasks the following day. Patients were representative of the intended user population in terms of age, gender, ethnicity, and education. Untrained participants attended a single study session where they were given as much time as needed to familiarize themselves with the On-Body Infusor and Instructions for Use. No education or training was provided.

when it’s time to start, furoscix is ready to go

prescribed doses are sent directly to your patient’s home

Patients receive a complete kit with all items needed for each dose

Each on-body infusor is single use and maintenance-free

the complete FUROSCIX kit
Once the On-Body Infusor is applied, it is activated with the press of a single button.

Click here to see how FUROSCIX is applied.

Administration and dosing

FUROSCIX delivers a fixed 80 mg of medication over 5 hours2:

  • 30 mg in the first hour
  • 12.5 mg per hour for the next 4 hours

The number of doses of FUROSCIX should be individualized based on the patient’s therapeutic response. FUROSCIX is not for chronic use and should be replaced with oral diuretics as soon as practical.

Any unused doses of FUROSCIX can be stored at room temperature. FUROSCIX has up to a 2-year shelf life.

Tolerability

  • FUROSCIX is formulated with a pH of 7.4 to minimize tissue irritation2,3
  • Systemic adverse reactions with FUROSCIX were consistent with those reported from patients administered IV furosemide2,4
  • The most common adverse reactions with FUROSCIX delivery were erythema, bruising, edema, and infusion site pain2
  • Monitoring of patients taking FUROSCIX is consistent with diuretic guidance5